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Medicinal plants have been known as one of the most important therapeutic agents since ancient times. During 
the last two decades, much attention has been paid to the health-promoting effects of edible medicinal plants, 
because of multiple beneficial effects and negligible adverse effects. Capparis spinosa L. is one of the most 
common medicinal plants, used widely in different parts of the world to treat numerous human diseases. This 
paper aims to critically review the available scientific literature regarding the health-promoting effects of 
C. spinosa, its traditional uses, cultivation protocols and phytochemical constituents. Recently, a wide range of 
evidence has shown that this plant possesses different biological effects, including antioxidant, anticancer and 
antibacterial effects. Phytochemical analysis shows that C. spinosa has high quantities of bioactive constituents, 
including polyphenolic compounds, which are responsible for its health-promoting effects, although many of 
these substances are present in low concentrations and significant changes in their content occur during process-
ing. In addition, there is negligible scientific evidence regarding any adverse effects. Different health promotion 
activities, as well as tremendous diversity of active constituents, make C. spinosa a good candidate for discover-
ing new drugs. However these findings are still in its infancy and future experimental and clinical studies are 
needed. 
Keywords: Capparis spinosa; caper; medicinal plant; polyphenolic compounds.
INTRODUCTION
Since ancient times, medicinal plants have been known
as one the most effective and safe therapeutic agents
for the treatment of human diseases (Dillard and
German, 2000; Raskin et al., 2002; Sen et al., 2010;
Nabavi et al., 2016). There are numerous medicinal
plants which possess multiple health-promoting effects
(Wink, 2012; Hu et al., 2013; Erdem et al., 2015; Nabavi
et al., 2015c). In addition, it is well known that synthetic
drugs can cause a wide range of serious adverse effects
(Gurney et al., 2014). Therefore, recent research has
focused on the beneficial role of medicinal plants in or-
der to ascertain effective and safe therapeutic strategies
for the treatment of human diseases (Schulz, 2006).
Nowadays, medicinal plants are known as an important
source of bioactive natural products such as phenols
and flavonoids (Ngameni et al., 2013; Nabavi et al.,
2015a; Russo et al., 2016). In addition, there are various
herbal formulates which possess beneficial effects on
human health (Bhattacharya and Kumar, 1997; Biswas
et al., 2001; Saraf, 2010). In view of the high efficacy
and low adverse effects of medicinal plants and their
bioactive constituents, these could serve as an important
alternative therapy for the treatment of different human
diseases including cardiovascular disease, neurodegen-
erative disease, etc. (Holst and Williamson, 2008;
Aggarwal and Sung, 2009; Banel and Hu, 2009; Kim
et al., 2010; Nabavi et al., 2014; Nabavi et al., 2015b).
Caper (Capparis spinosa L.) is a common member of
the genus Capparis (Capparidaceae family) (Tlili et al.,
2011). This genus contains more than 250 flowering
species which are distributed throughout different
habitats from subtropical to tropical zones (Inocencio
et al., 2006). The Caper is a perennial shrub, thorny,
0.3–1m tall, and is commonly known by different names
including Caper (English) (Tlili et al., 2011), Alaf-e-Mar
(Persian) (Asl et al., 2012), Cappero (Italy) (Barbera
and Di Lorenzo, 1983) and Alcaparro (Spain) (Tlili
et al., 2011). The plant has deep roots which can extend
up to 6–10m. C. spinosa is widely distributed in different
parts of the world ranging from Morocco to Crimea,
Armenia and Iran (Rivera et al., 2003; Tlili et al.,
2011). It has been reported that C. spinosa demon-
strated significant resistance to different biotic and
abiotic stresses (Tlili et al., 2011).
Over the past two decades, much attention has been
paid to the pharmacological effects of C. spinosa be-
cause of its high number of bioactive constituents, espe-
cially its polyphenolic compounds (Bonina et al., 2002;
Germano et al., 2002; Tesoriere et al., 2007; Tlili et al.,
2010). Phytochemical analysis showed that different
parts of C. spinosa are rich sources of polyphenols and
research has thus been focused on the health-promoting
effects of this plant and its active constituents (Bonina
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et al., 2002; Germano et al., 2002; Tesoriere et al., 2007;
Tlili et al., 2010). Up to now, there has been much
scientific evidence showing that C. spinosa possesses
different pharmacological effects including antioxidant,
antimicrobial, anticancer and hepatoprotective
effects (Mishra et al., 2007; Tesoriere et al., 2007; Lam
and Ng, 2009; Aghel et al., 2010; Tlili et al., 2010; Gull
et al., 2015).
Despite this, there are no review papers addressing
the effects of this plant. Therefore, this paper aims
to critically review available scientific reports regard-
ing the pharmacological effects of C. spinosa in order
to provide a broad spectrum on this plant. In addition,
we provide some information about the traditional
uses, cultivation and phytochemical constituents of
this plant.
TAXONOMIC REVISION OF GENUS CAPPARIS
In the plant database ‘The plant list’ (http://www.
theplantlist.org/), 813 plant name records match the
search criteria ‘Capparis’. Actually, the genus Capparis
L., which was created by Linnaeus, comprises about
250 flowering species, which are distributed throughout
different habitats, from subtropical to tropical zones of
Africa, Asia, Australia, southern America and Europe
(Inocencio et al., 2006). In the same database, searching
the name ‘Capparis spinosa L.’, this record is reported
as the accepted name of a species, to which 22 synonyms
correspond by which this species has been known. In-
deed, the classification of genus Capparis and C. spinosa
is critical because of the several taxa that has been pro-
posed since the nineteenth century, when Candolle set
up the first taxonomic approach to Capparis, including
C. spinosa, and other species such as C. cartilaginea
Decne (Candolle, 1869). Since then, several taxa have
been described. In 1960, Zohary (1960) recognized in
the ‘C. spinosa group’ three tropical species, including
C. decidua, C. cartilaginea, C. mucronifolia Boiss. and
three Mediterranean species, including C. spinosa,
C. sicula Veill., C. leucophylla DC. Each species was in
turn subdivided into some varieties. Few years later,
Jacobs (1964) reported that C. spinosa consists of one
species, subdivided into five varieties, which were
geographically differentiated. This type of classification,
in which C. spinosa is a single species subdivided into
several varieties, was proposed by other authors such
as Maire (Maire, 1965), Higton et al. (Higton and
Akeroyd, 1991) and Fici (Fici, 2003). In more recent
times, Inocencio et al. (2006) recognized 10 species and
12 subspecies of C. spinosa growing in the Mediterra-
nean area (North Africa, Western Asia and Europe),
and central Asia. Finally, in 2014 (Fici, 2014), the most
recent taxonomic revision was proposed by Fici. He
recognized only one species in the same area studied
by Inocencio et al., subdivided into two subspecies
(subdivided into four varieties), C. spinosa subsp.
spinosa and C. spinosa subsp. rupestris. On the above,
when phytochemical and pharmacological investigations
are conducted on members of the ‘C. spinosa group’,
right and updated taxonomic aspects should be clarified
in order to correlate the chemical composition and
biological activities depending on the geographic origin
and ecotype of the samples.
TRADITIONAL USES OF C. SPINOSA
In traditional medicine, different parts of C. spinosa
have been widely used for the treatment of various hu-
man diseases (Eddouks et al., 2004; Mishra et al., 2007;
Polat, 2007). It has been reported that the aerial parts
and roots of C. spinosa have been used for the treatment
of rheumatism, gastrointestinal problems, headache,
kidney and liver disease as well as toothache (Esiyok
et al., 2004; Mishra et al., 2007; Sher and Alyemeni,
2010; Zhou et al., 2010; Lansky et al., 2013). The leaf,
roots and buds of C. spinosa have been suggested by
Arabian traditional medicine for the treatment of differ-
ent human diseases such as spleen diseases, stomach
problems, skin diseases, earache and kidney diseases
as well as hepatic diseases (Al-Qura’n, 2009; Sher and
Alyemeni, 2010; Tlili et al., 2011). In addition, it has
been recommended for the treatment of paralysis, con-
vulsions and gum problems (Rivera et al., 2003; Jiang
et al., 2007; Tlili et al., 2011). Its fruits have been tradi-
tionally used for the treatment of diabetes, headache,
fever and rheumatism (Rivera et al., 2003; Jiang et al.,
2007; Tlili et al., 2011). It has also been reported that
the roots, fruit and bark of C. spinosa have been used
as diuretic, tonic and antimalarial agents in Iranian
traditional medicine (Miraldi et al., 2001; Ahvazi et al.,
2011; Mosaddegh et al., 2012). Moreover, the leaves of
C. spinosa have been traditionally used as analgesic,
anti-hemorrhoid, antirheumatic and antiinflammatory
agents (Tlili et al., 2011). It has also been reported that
C. spinosa possesses a beneficial effects on coughs and
asthma (Jiang et al., 2007). In addition, the flowers of
C. spinosa have been suggested as stimulants to increase
erection (Jiang et al., 2007).
CULTIVATION OF C. SPINOSA
C. spinosa is commonly cultivated in tropical and sub-
tropical zones (Barbera et al., 1991; Fici and Gianguzzi,
1997; Fici, 2001), and is widely grown in dry, well-
drained soil and full sun (http://www.pfaf.org/user/
Plant.aspx?LatinName=Capparis+spinosa). However,
it can be cultivated in poor soils as well as rocky areas
and mountains (Fici and Gianguzzi, 1997; Rivera et al.,
2002). It has also been reported that this species can
be widely grown in different varieties of soil such as
alfisols, regosols and lithosols (Mohammad et al.,
2012). It has been reported that C. spinosa possesses
an acceptable response to alkaline soils (Mohammad
et al., 2012), but the most suitable soil pH for its cultiva-
tion is in the range of 6.3 to 8.3. It is well known that
C. spinosa grows widely in rainy habitats from April
to May, commonly disappearing in colder months,
from October onwards (Moghaddasi, 2011; Tlili et al.,
2011; Mohammad et al., 2012). To date, C. spinosa has
been widely produced in different countries such as
Iran, Turkey, Greece, Morocco, Italy, Spain, etc.
(Moghaddasi, 2011; Tlili et al., 2011; Mohammad et al.,
2012). It has been reported that the average annual pro-
duction is approximately 10 000 tonnes and Turkey is
known as the most important source of production (Tlili
et al., 2011). It has also been reported that the USA is an
important consumer (Tlili et al., 2011). It is well known
that there is a close correlation between production of
C. spinosa and levels of fertilizers in the soil (Tesi
et al., 2000; Tlili et al., 2011). In addition, vegetative
cuttings are known as one the most common protocols
for propagation of this plant. The best time for propaga-
tion is winter (Macchia and Casano, 1993; Musallam
et al., 2011).
PHYTOCHEMISTRY OF C. SPINOSA
In terms of phytochemical constituents, C. spinosa is by
far one of the most studied medicinal plants to date. The
chemical compositions of the various parts include
alkaloids, flavonoids, glucosinolates, phenolic acids,
terpenoids and more. This review is not intended as a
comprehensive review of the chemistry; however a brief
summary of the major chemical classes of the identified
compounds is presented to assist readers in understand-
ing the true therapeutic potential of the plant. In Table 1
a summary of the compounds naturally occurring in C.
spinosa and the analytical methods used to determine
these substances is reported.
Alkaloids
Alkaloids are a diverse group of secondary natural me-
tabolites containing one or more nitrogen atoms in their
structure. Among the various alkaloids isolated from C.
spinosa so far is the novel tetrahydroquinoline acid (1)
from the stems and fruits of the plant (Zhang et al.,
2014). In fact, this compound can be regarded as a novel
amino acid as it contains a carbon skeleton that carries
both amino and carboxylic acid groups. Another
modified amino acid or alkaloid is (2) which has been
isolated from fruits (Fu et al., 2007). The fruits of C.
spinosa also yield highly polar, water-soluble alkaloids
capparisine A (3), capparisine B (4), capparisine C (5),
2-(5-hydroxymethyl-2-formylpyrrol-1-yl) propionic acid
lactone (6) and N-(3′-maleimidy1)-5-hydroxymethyl-2-
pyrrole formaldehyde (7) (Yang et al., 2010). In another
study that focused on chemical investigation of the
roots, Fu et al. (2008) isolated three new spermidine
alkaloids named capparispine (8), capparispine 26-O-β-
D-glucoside (9) and cadabicine 26-O-β-D-glucoside
hydrochloride (Fig. 1) (10).
Flavonoids
Flavonoids are one of the most diverse polyphenolic
natural products, constructed from a 15 carbon skeleton:
two aromatic 6-membered rings joined by a 3-carbon
chain. Biosynthetically, the C6 aromatic and C3-side
chains are derived from the shikimic acid pathway while
the other aromatic ring originates in the acetate pathway.
Depending on the cyclization of the linking chain to form
the third ring; the site of attachment of the aromatic ring
at the side chain and the chemical nature of the linking
chain including presence/absence of double bond, oxida-
tion pattern, etc.; flavonoids can be grouped into several
sub-classes. These include flavones, flavonols, flavanones,
chalcones, isoflavonoids and neoflavonoids. Because of
their diverse pharmacological effects ranging from
antidiabetic (Habtemariam, 2011; Habtemariam and
Varghese, 2014) and antiinflammatory (Habtemariam,
2000) to anticancer effects (Habtemariam, 1997), flavo-
noids are among the best studied natural products. Inter-
estingly, various classes of flavonoid sub-groups are
represented in C. spinosa. One of the most abundant
flavonoids in nature, quercetin (11), has been isolated
from the buds of the plant (Rodrigo et al., 1992) while var-
ious derivatives of its glycosides (12–15) have been identi-
fied in the fruits and other parts of the plant (Sharaf et al.,
2000). Themost abundant flavonoid, both in the buds and
fruits, appears to be rutin (12) (Rodrigo et al., 1992; Sharaf
et al., 2000; Germano et al., 2002; Giuffrida et al., 2002).
The quercetin derivative aglycon, isorhamnetin (16)
and its rutinoside glycoside (17) have also been isolated
by various authors (Siracusa et al., 2011). The other
flavonoid of structural significance was kaempferol (18)
and its glycosides (19, 20) that have been isolated as
minor principles from the fruits and buds (Inocencio
et al., 2000; Argentieri et al., 2012). Sakuranetin (21) is
a flavanone derivative while wogonin (22) and oroxylin
A (23) are examples of flavones identified in the various
parts of the plant (Li et al., 2007). Two dimeric
flavonoids (24, 25) that are characteristic markers of
Ginkgo biloba are also identified in C. spinosa (Fig. 2)
(Zhou et al., 2011).
Effect of berries processing on phenolic composition
The content of flavonoids in caper is subjected to
several changes depending on different factors such as
processing, pH, extraction method, fermentation etc.
Before use as a food, usually caper berries are tradition-
ally fermented in brine using lactic acid bacteria such as
Lactobacillus pentosus (Pérez Pulido et al., 2005). This
bacterium is helpful in reducing the bitter taste of
unprocessed caper products because of the presence of
phenolic compounds. In a study of Francesca et al.
(2016) caper berries fermented with L. pentosus were
analyzed for the presence of flavonoids by HPLC-ESI-
MS and compared with non-fermented batches. Results
showed that fermented caper berries have a phenolic
profile different with respect to that of unprocessed
fruits. Notably, during fermentation quercetin was
formed by hydrolysis of rutin upon activity of different
enzymes (Lin et al., 2014; Tranchimand et al., 2010).
Rutin was the most abundant flavonoid occurring in
both fermented and unprocessed samples. Conversely,
epicatechin was found only in raw berries.
Glucosinolates and their derivatives
Glucoinolates are a group of natural compounds that
contain glucose and amino acid derivatives. Structurally
they are constructed from compounds with unique sul-
fur and nitrogen functional groups, giving plants their
characteristic odors and biological activities. Among
the various glucosinolates identified in the various
tissues of C. spinosa are 26–30 (Fig. 3) (Ahmed et al.,
1972; Schraudolf, 1989).
The remarkable feature of glucosinolates in plants is
their ability to give rise to a host of secondary metabo-
lites, primarily because of myrosinase enzyme activity.
The liberated compounds include small molecular
 Table 1. Chemical classes, compounds and analytical methods used to determine the substances naturally occurring in C. spinosa
Chemical class Identified compound Analytical method Reference
Alkaloid Tetrahydroquinoline HPLC via chiral column Zhang et al., 2014
Alkaloid Stachydrin UV, IR, mass spectrometry and
PMR
Fu et al., 2007
Alkaloid Capparisine A Silicagel column chromatography,
reversed-phase HPLC, NMR, X-ray
crystallographic analysis
Yang et al., 2010
Alkaloid Capparisine B Silicagel column chromatography,
reversed-phase HPLC, NMR, X-ray
crystallographic analysis
Yang et al., 2010
Alkaloid Capparisine C Silicagel column chromatography,
reversed-phase HPLC, NMR
Yang et al., 2010
Alkaloid 2-(5-Hydroxymethyl-2-
formylpyrrol-1-yl) propionic acid
lactone
Silicagel column chromatography,
reversed-phase HPLC, NMR
Yang et al., 2010
Alkaloid N-(3′-Maleimidy1)-5-
hydroxymethyl-2-pyrrole
formaldehyde
Silicagel column chromatography,
reversed-phase HPLC, NMR
Yang et al., 2010
Alkaloid Capparispine Silicagel column chromatography,
1D and 2D NMR
Fu et al., 2008
Alkaloid Capparispine 26-O-β-D-glucoside Silicagel column chromatography,
1D and 2D NMR
Fu et al., 2008
Alkaloid Cadabicine 26-O-β-D-glucoside
hydrochloride
Silicagel column chromatography,
1D and 2D NMR
Fu et al., 2008
Flavonoid Quercetin HPLC analysis Rodrigo et al., 1992
Flavonoid Rutin or Quercetin rutinoside HPLC analysis Rodrigo et al., 1992
PPC, silicagel chromatography, gel
filtration chromatography, NMR
Sharaf et al., 2000
HPLC-DAD analysis Germano et al., 2002
HPLC analysis Giuffrida et al., 2002
Flavonoid Quercetin rhamnoside HPLC analysis Rodrigo et al., 1992
PPC, silicagel chromatography, gel Sharaf et al., 2000
Flavonoid Isoquercetin HPLC analysis Rodrigo et al., 1992
PPC, silicagel chromatography, gel
filtration chromatography, NMR
Sharaf et al., 2000
Flavonoid Quercetin [6″-α-L-rhamnosyl-6″-O-
β-D-glucosyl]-β-D-glucpyranoside
HPLC analysis Rodrigo et al., 1992
PPC, silicagel chromatography, gel
filtration chromatography, NMR
Sharaf et al., 2000
Flavonoid Isorhamnetin HPLC/UV–vis-DAD/ESI-MS Siracusa et al., 2011
Flavonoid Isorhamnetin rutinoside HPLC/UV–vis-DAD/ESI-MS Siracusa et al., 2011
Flavonoid Kaempferol HPLC analysis Inocencio et al., 2000
HPLC/UV–vis-DAD/ESI-MS/MS Argentieri et al., 2012
Flavonoid Kaempferol rutinoside HPLC analysis Inocencio et al., 2000
HPLC/UV–vis-DAD/ESI-MS/MS Argentieri et al., 2012
Flavonoid Kaempferol rhamnosyl-rutinoside HPLC analysis Inocencio et al., 2000
HPLC/UV–vis-DAD/ESI-MS/MS Argentieri et al., 2012
Flavonoid Sakuranetin —* Li et al., 2007
Flavonoid Wogonin —* Li et al., 2007
Flavonoid Oroxylin A —* Li et al., 2007
Flavonoid Isoginkgetin HPLC/UV–vis-DAD/ESI-MS, NMR Zhou et al., 2011
Flavonoid Ginkgetin HPLC/UV–vis-DAD/ESI-MS, NMR Zhou et al., 2011
Glucosinolate Glucocapparin Paper chromatography Ahmed et al., 1972
HPLC and MS spectral method Schraudolf, 1989
Glucosinolate Glucoiberin Paper chromatography Ahmed et al., 1972
HPLC and MS spectral method Schraudolf, 1989
Glucosinolate Glucobrassicin Paper chromatography Ahmed et al., 1972
HPLC and MS spectral method Schraudolf, 1989
Glucosinolate Neoglucobrassicin Paper chromatography Ahmed et al., 1972
HPLC and MS spectral method Schraudolf, 1989
Glucosinolate 4-Methoxy-glucobrassicin Paper chromatography Ahmed et al., 1972
HPLC and MS spectral method Schraudolf, 1989
(Continues) 
weight biologically active compounds such as butyl and
isopropyl isothiocyanates (31–32, (Afsharypuor et al.,
1998)) and indole-3 acetonitrile glycosides (33, 34,
(Çaliş et al., 1999; Fu et al., 2007)) all of which have been
isolated from C. spinosa (Fig. 4). The levels of butyl-
isothiocyanate and isopropyl-isothiocyanate in the leaf
oil of C. spinosa were found to be 6 and 11%,
Table 1. (Continued)
Chemical class Identified compound Analytical method Reference
Glucosinolate Butyl-isothiocyanate GC-MS Afsharypuor et al., 1998
Glucosinolate Isopropyl-isothiocyanate GC-MS Afsharypuor et al., 1998
Glucosinolate Cappariloside A RP-chromatography, UV, IR, 1D-e
2D-NMR, ESI, FAB-mass
spectrometry
Çaliş et al., 1999
UV, IR, mass, PMR, NMR Fu et al., 2007
Glucosinolate Cappariloside A glucose RP-chromatography, UV, IR, 1D-e
2D-NMR, ESI, FAB-mass
spectrometry
Çaliş et al., 1999
UV, IR, mass, PMR, NMR Fu et al., 2007
Benzofuranone 2-(4-Hydroxy-2-oxo-2,3-
dihydrobenzofuran-3-yl)acetonitrile
HPLC via chiral column, NMR, OR,
ECD
Zhang et al., 2014
Fatty acyl glycosides Prenyl glucoside Çaliş et al., 1999
3-Oxo-α-ionol glucoside
derivative
Corchoionoside C or (6S)-hydroxy-
3-oxo-α-ionol glucoside
UV, IR, ESI, NMR, ORD, CD Çaliş et al., 1999
3-Oxo-α-ionol glucoside
derivative
Spionoside A or (6S)-hydroxy-3-
oxo-α-ionol glucoside
UV, IR, ESI, NMR, ORD, CD Çaliş et al., 1999
3-Oxo-α-ionol glucoside
derivative
Spionoside B or (6S)-hydroxy-3-
oxo-α-ionol glucoside
UV, IR, ESI, NMR, ORD, CD Çaliş et al., 1999
Sterol β-Sitosterol —* Yu et al., 2006
Sterol β-Sitosterol glycoside — Yu et al., 2006
Phenolic acid p-Idroxybenzoic acid — Yu et al., 2006
Phenolic acid Protocatechuic acid — Yu et al., 2006
Phenolic acid p-Methoxy benzoic acid — Yu et al., 2006
UV, IR, NMR, MS Gadgoli and Mishra, 1999
* The manuscript is not available.
Figure 1. Chemical structures of alkaloids of C. spinosa.
Figure 2. Chemical structures of flavonoids of C. spinosa.
respectively, while the two compounds are the main
components of the fruit and root oils (Afsharypuor
et al., 1998).
Other classes of compounds
Zhang et al. (2014) have isolated two novel
benzofuranone enantiomers (35, 36) from the fruits
and stem of C. spinosa (Fig. 5). A prenyl glucoside
(37) and three (6S)-hydroxy-3-oxo-α-ionol glucosides
(38–40) were also isolated from the fruits (Çalış
et al., 2002) along with the common phytosterol β-
sitosterol (41) and its glycoside (42) (Fig. 5) (Çalış
et al., 2002).
In addition to the triterpene constituents (41, 42),
Yu et al. (2006) have identified three phenolic acids
(43–45) from the fruits of C. spinosa along with
butanedioic acid, uracil and uridine (Fig. 5). While
studying the antihepatotoxic activity of the plant,
Gadgoli and Mishra (1999) have identified p-methoxy
benzoic acid (45) as the active principle. The isolation
of nucleotide bases including uracil, hypoxanthine and
adenosine from the fruit has also been described by
Fu et al. (2007) A number of authors have also ex-
amined the composition of the seed oil of C. spinosa
and the major constituents were established to be
oleic (27%) and linoleic (31%) acids followed by
palmitic and a rare lipid, vaccenic acid (Matthäus
and Özcan, 2005; Argentieri et al., 2012). The small
molecular weight and nonpolar glucoinolate products
are also found in the seed and leaf extracts
(Argentieri et al., 2012).
PHARMACOLOGICAL EFFECTS OF C. SPINOSA
The different parts of C. spinosa contain a wide range of
secondary metabolites endowed with several docu-
mented biological effects (assessed between 2010 and
2016) which were summarized as follows.
Antioxidant
Different parts of caper were investigated for their anti-
oxidant effects, potentially useful against some degener-
ative diseases. An aqueous infusion from flower tops of
capers growing in Croatia was analyzed for antioxidant
activity before and after in vitro digestion (Siracusa
et al., 2011). Before digestion, the antioxidant activity,
measured through the 1,1-diphenyl-2-picrylhydrazyl
(DPPH) method, β-carotene bleaching method and
copper-induced oxidation of human low-density lipo-
protein (LDL), was found to be strong and dose depen-
dent. This activity may be related to bioactive
constituents such as rutin, kaempferol 3-O-rutinoside,
isorhamnetin 3-O-rutinoside and cinnamoylquinic acid
derivatives. However, after in vitro digestion, most of
phenolic compounds undergo degradation. As a
consequence, the antioxidant activity of the infusion de-
creases significantly. Interestingly, the loss of phenolic
compounds is dependent on the type of initial matrix,
the caper infusion being less exposed to degradation
(Siracusa et al., 2011).
The methanolic extracts of seeds collected in various
localities of Tunisia were assayed for their antioxidant
power by total antioxidant capacity (TAC), DPPH and
2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS) radical scavenging activity (Tlili et al., 2015).
Results show that the content of polyphenols in extracts
varies according to their geographic origin and climatic
conditions. The compounds detected in all samples were
gallic acid, naringin, morin, methly-4-hydroxybenzoate,
genistein, flavonose and chalcone. The total antioxidant
activity of caper seeds reaches high values (33–78
GAE/g DR) compared to standard quercetin, although
significative variations occur between samples of
Figure 3. Chemical structures of glucosinolates of C. spinosa.
Figure 4. Chemical structures of isothiocynates and indole-3 ace-
tonitrile glycosides of C. spinosa.
Figure 5. Chemical structures of benzofuranone enantiomers,
prenyl glucoside, (6S)-hydroxy-3-oxo-α-ionol glucosides,
triterpene, β-sitosterol and its glycoside.
different origin (Tlili et al., 2015). The radical scaveng-
ing activity, determined by DPPH and ABTS methods,
was noteworthy in some cases, with IC50 values (3.5
and 2.6μg/mL, respectively) lower than those of positive
controls such as BHT and Trolox (17.3 and 3.5μg/mL,
respectively). Based on the above results, caper seeds
seem to be a good source of antioxidant compounds,
mainly flavonoids and tannins, for use in the food and
pharmaceutical industries.
The methanolic extract of caper buds from Algeria
shows noteworthy radical scavenging activity against
DPPH radicals with an IC50 value of 53μg/mL. This ac-
tivity results higher than that of the reference butylated
hydroxytoluene (BHT). On the other hand, its chelating
activity on ferrous ions is moderate, with an IC50 value
of 190μg/mL (Bouriche et al., 2011). The antibacterial
activity of the same extract on the gram-positive Entero-
coccus faecalis, Staphylococcus aureus, Bacillus subtilis
(minimum inhibitory concentration (MIC) of 10.6μg/
mL in all cases) and on the gram-negative Pseudomonas
aeruginosa (MIC of 2.69μg/mL), Escherichia coli,
Citrobacter sp. and Serratia marcescens (MIC of
5.31μg/mL in all cases) is worthy of mention. Taken
together, these results may support the use of caper
extract as a promising food preservative.
Cognitive dysfunctions are often related to an exces-
sive oxidative stress of brain cells, including hypoxic
stress and ischemic injury (Attrey et al., 2012). In this
regard, flavonoids have been proven to act as radical
scavengers, thus reducing oxidative stress and brain
tissue damage (Dragicevic et al., 2011). In an in vivo
study conducted on Balb/c mice administered with
D-galactose, the effects of caper seed extract on
cognitive impairment and oxidative stress in Alzheimer
disease models were evaluated (Turgut et al., 2015). An
administration of caper extract was found to provide
significant protection against DNA damage, decrease
malondialdehyde (MDA) levels and increase superoxide
dismutase (SOD), glutathione peroxidase (GPx) and
catalase (CAT) activities. Syringic acid was shown to
play an important role in providing this effect as a main
constituent of the caper seed extract administrated to
animals. This study demonstrated that C. spinosa extract
significantly improves cognitive impairment induced by
D-galactose injection in mice in a dose-dependent man-
ner (Turgut et al., 2015). This effect is likely achieved
through attenuating oxidative stress as demonstrated
by increasing activities of SOD, GPx and CAT enzymes
and decreasing levels of MDA.
Another study evaluated the effects of an aqueous
extract from C. spinosa buds using an animal model of
Alzheimer’s disease (AD) (Goel et al., 2016). LPS-
treated Sprague–Dawley rats were used for the purpose
and evaluated using the Morris water maze test. Acqui-
sition and memory, which were decreased after treat-
ment with LPS, were restored when LPS-treated
animals were orally administered with extract of C.
spinosa (10mg/rat pre-treatment, 30mg/rat post-
treatment). The observed reduction in loss of memory
has been linked to the immunomodulatory and curative
properties of C. spinosa extract against LPS induced
neuroinflammation (Ihme et al., 1996; Ageel et al.,
1985). Also the percentage alternation, that is a measure
of the animal responsiveness towards novelty and as
working memory, was increased in groups treated with
caper extract. Histological examinations of hippocampal
area and cerebral cortex revealed that the post-
treatment group showed a significant reduction of
degenerative changes and shrinkage of neuronal bodies
meaning neuroprotective activity of caper extract.
In another in vivo study, the protective effects of a
hot-water extract of C. spinosa were evaluated on lipid
peroxidation induced by lead acetate in rats (Al-Soqeer,
2011). In particular, biochemical alterations such as
glutathione-S-transferase activity reduction, and in-
creases in serum triglycerides, urea, aspartate transami-
nase (AST) and alanine transaminase (ALT) were
found to return to normal values after an administration
of C. spinosa hot-water extract. This activity is assumed
to be driven by flavonoids such as quercetin and
kaempferol derivatives (Al-Soqeer, 2011).
Fruits of C. spinosa growing in Bahrain were evalu-
ated for antioxidant properties by using different assays
such as ferric reducing ability of plasma (FRAP), DPPH
and ABTS methods (Allaith, 2016). Methanolic extracts
of fruits displayed an average value of 9.06mmol
TEAC/kg fw in the FRAP assay, which is relevant when
compared to those of other foods and wild berries. The
reduction potential of caper fruits may be because of
thiols and sulfur containing compounds (Afsharypuor
et al., 1998; Romeo et al., 2007). Radical scavenging ac-
tivity on DPPH and ABTS was calculated as 6.13mmol
and 8.12 TEAC/kg fw, respectively. The average total
phenolic content was 120mg GAE/100 g, a higher value
than that reported for Turkish and Italian caper (Bonina
et al., 2002; Aliyazicioglu et al., 2013). The major
contributors to the antioxidant activity of caper fruits
are believed to be water soluble compounds such as
phenolic acids and flavonoids.
The ethanolic extract of fruits of C. spinosa (ECS)
was evaluated against oxidative stress in systemic sclero-
sis (SSc) dermal fibroblasts in vitro (Cao et al., 2010).
Administration of ECS at different concentrations
(10, 50 and 100g/mL) significantly reduced in a dose-
dependent manner the formation of O2, H2O2 and
ROS. Furthermore, ECS ameliorates cell availability
and protected against apoptosis induced by H2O2 in
SSc fibroblasts. In particular, ECS reduced the expres-
sion of Ha-Ras protein and phosphorylated forms of
ERK/2 in SSc fibroblast in a dose-dependent manner
(Cao et al., 2010). These effects might be because of fla-
vonoids such as quercetin and kaempferol derivatives,
and hydroxycinnamic acids (Bonina et al., 2002). These
results suggest the potential application of ECS in the
treatment of skin sclerosis.
The essential oil obtained from caper leaves by
hydrodistillation and characterized by high amounts of
methyl isothiocyanate (92.0%) did not show significant
radical scavenging activity through the DPPH method,
whereas it did show antioxidant activity through the
β-carotene bleaching method and thiobarbituric acid
reactive species assay (Kulisic-bilusic et al., 2010).
Anticarcinogenic
The essential oil hydrodistilled from leaves and floral
buds of C. spinosa and the water infusion prepared with
the same were assayed for anticarcinogenic potential on
HT-29 human colorectal adenocarcinoma cells (Kulisic-
Bilusic et al., 2012). The essential oil composition was
dominated by methyl isothiocyanate, the product
originated by glucocapparin degradation, while the
water infusion was a good source of flavonoids known
for antiproliferative effects against colon cancer cells.
Both the essential oil and aqueous infusion exert a
time- and dose-response reduction of the proliferation
of HT-29 cells, with the former showing slightly lower
activity than the latter (44.3% of inhibition after 72h
vs. 54.4%, respectively). Furthermore, the effects on
nuclear factor kappa B (NF-kB) activation were
studied. Essential oil and aqueous infusion showed a
dose-dependent effect on NF-kB activity, with the latter
again more active than the former (54.8% of inhibition
vs. 19.0%, respectively). Finally, the essential oil and
aqueous infusion of caper induce a G2/M arrest in a
dose-dependent manner (Kulisic-Bilusic et al., 2012).
Overall both caper products were proven to exhibit cyto-
static and not cytotoxic effects on HT-29 cells. The major
components of the aqueous infusion, such as chlorogenic
acid and rutin, did not show comparable activities to
those of the complex mixture in which they occur.
Antiquorum sensing and antibiofilm potential
The methanolic extract obtained from the fruits of C.
spinosa was assayed for antiquorum sensing (anti-QS)
activity in Chromobacterium violaceum and P.
aeruginosa, and for antibiofilm formation in E. coli,
Proteus mirabilis, S. marcescens and P. aeruginosa
(Abraham et al., 2011). The methanolic extract, at
2mg/mL, exhibits strong anti-QS activity in the violacein
inhibition assay (88% reduction of violacein content) in
a dose-dependent manner, and does not inhibit bacterial
growth as revealed by the agar disk diffusion method. At
2mg/mL this extract reduced biofilm formation and
exopolysaccharide production (EPS) to 58, 46, 66 and
67% in S. marcescens, P. aeruginosa, E. coli and P.
mirabilis, respectively. In conclusion, the fruits of C.
spinosa showed a promising potential to be exploited in
the treatment of emerging infections of antibiotic resis-
tant bacterial pathogens.
Antiinflammatory
The aqueous extract of the fruits of C. spinosa was
evaluated for antiinflammatory activity in carrageenan-
induced paw edema in mice (Zhou et al., 2010). Differ-
ent fractions (named CSF1, CSF2 and CSF3) separated
from the aqueous extract by macroporous adsorption
resins were orally administrated to male Chinese Kun
Ming (KM) mice. The antiinflammatory effects
exhibited by these fractions were compared with those
of indomethacin used as positive control. Only CSF2
and CSF3, at 50 and 250mg/kg at 6 h after induction,
inhibited the edema in mice in a dose-dependent man-
ner (24.0 and 40.8%, and 31.0 and 39.3%, respectively).
The inhibition given by the positive control was 20.9%.
The most active fractions CSF2 and CSF3 were
submitted to column chromatography on silica gel for
isolation and purification of bioactive constituents. A
total of 13 compounds were isolated and structurally
elucidated by ESI-MS and 1H and 13C NMR (Zhou
et al., 2010). They were identified as flazin, guanosine,
capparine A, capparine B, 1H-indole-3-carboxaldehyde,
4-hydroxy-1H-indole-3-carboxaldehyde, chrysoeriol,
apigenin, kaempferol, thevetiaflavone, 5-hydroxy-
methylfuraldehyde, vanillic acid and cinnamic acid.
Some of them are therefore potential candidates as
natural antiinflammatory drugs, although the possibility
of synergistic effects among the fruit constituents has to
be taken into account.
In another study Zhou et al. (2011) isolated several
flavonoids and biflavonoids from the fruits of C. spinosa
and evaluated their effects on NF-kB activation through
a secreted placental alkaline phosphatase (SEAP)
reporter assay. NF-kB is involved in the regulation of
expression of important inflammatory mediators, thus
representing a potential target for antiinflammatory
therapeutics. In this study, the isolated biflavonoid
ginkgetin showed strong inhibitory effects on NF-kB
activation with an IC50 value of 7.5μM. The SEAP
reporter assay was conducted on RAW-Blue cells
pretreated with LPS.
Anti-arthritic activity
In traditional Chinese medicine (TCM) caper is used to
treat rheumatic arthritis and gout. In order to support
this traditional medical use, the ethanol-water (70:30)
extract of caper fruit, together with four of its fractions,
was assayed on male Wistar rats and on male and female
Imprinting Control Region (ICR) mice for anti-arthritic
activity (Feng et al., 2011). Adjuvant arthritis was
induced by intradermal injection of Freund adjuvant
into the right hind paw of animals. Diclofenac sodium
was used as a positive control. After 27days rats were
sacrificed and thymus and spleen were weighted, while
the immune organ coefficient was calculated.
Analgesic and antiinflammatory activities were
studied by determining nociception induced by acetic
acid and hot-plate, and inflammation induced by
carrageenan and xylene. The fractions with the highest
activity were subjected to column chromatography
yielding p-hydroxy benzoic acid, 5-(hydroxymethyl)
furfural, bis(5-formylfurfuryl)ether, daucosterol, α-D-
fructofuranosides methyl, uracil and stachydrine as the
major compounds. Notably, fraction 2 was the most
active as an anti-arthritic drug, showing efficacy compa-
rable to that of diclofenac. This fraction, rich in
stachydrine, was able to delay the response to thermal
stimulation and inhibited the abdominal constriction
response caused by acetic acid. Ear and paw edema
caused by xylene and carrageenan were also reduced
(Feng et al., 2011). This study corroborated the tradi-
tional use of caper in China as an antiinflammatory
and anti-arthritic agent.
Immunomodulatory activity
The methanolic extract of C. spinosa buds, rich in flavo-
noids such as quercetin and kaempferol derivatives, was
proven to exert in vitro immunomodulatory effects in
human peripheral blood mononuclear cells (PBMCs)
(Arena et al., 2008). In particular, the administration of
extract inhibited the herpes simplex virus type 2 (HSV-
2) replication in PBMCs by upregulating the expression
of proinflammatory cytokines such as IL-12, IFN-γ and
TNF-α.
Further in vitro and in vivo studies on the methanolic
extracts of leaves and fruits of C. spinosa confirmed the
immunomodulatory activity (Aichour et al., 2016). In
the lymphoproliferation assay, the methanolic extracts
at 400μg/mL showed significant increases in the prolif-
eration of cells in the presence of the mitogen concanav-
alin A (10μg/mL). In cyclophosphamide-treated and
myelosuppressed Wistar mice, the administration of
100 and 200mg/kg bwt of both methanolic extracts in-
creased significantly the level of the total white blood
cells (WBC). This effect is probably mediated by flavo-
nol derivatives occurring in the extracts (Aichour et al.,
2016). Based on these results, C. spinosa can be a valid
complementary therapeutic agent to be used in the
treatment of diseases caused by immune dysfunction.
Antidiabetic activity
The ethanolic extract of C. spinosa fruit was assessed for
antihyperglycemic and antihyperlipidemic activity using
nicotinamide (NA) and streptozotocin (STZ) induced
diabetic rats (male adult albino type) (Mishra et al.,
2012). The diabetic rats were treated orally with C.
spinosa fruit extract (200 and 400mg/kg bw) for 28days,
while the control group was treated orally with 25mg/kg
bw of gliclazide. In this study the biochemical parame-
ters of type-II diabetic animals treated with C. spinosa
fruit extract at the highest dose were significantly
improved and the blood glucose level was reduced as
compared to diabetic control group.
More important, in a controlled human study the effi-
cacy of C. spinosa fruit extract as an anti-hyperglycemic
agent was evaluated (Huseini et al., 2013). In this ran-
domized double-blind placebo-controlled clinical trial,
54 type 2 diabetic patients (Iranian male and female
type 2 diabetic patients) were divided in two groups of
28 and 26 patients on standard anti-diabetic therapy,
the first group received 400mg caper fruit extract (etha-
nol 70%) three times a day for two months, with the sec-
ond group receiving placebo capsules. Blood glucose,
glycosylated hemoglobin, lipid levels, liver and renal
function tests were measured at the beginning and end
of the clinical trial. Treatment with C. spinosa fruit
extract showed significant reduction in fasting blood
glucose levels and glycosylated hemoglobin compared
to the control group at the end of the study. Triglyceride
levels also decreased significantly at the end of the study
compared to baseline. Notably, no side effects were
observed in caper-treated patients. Results of this study
support the traditional use of caper in the treatment of
diabetes (Yaniv et al., 1987) and stimulate additional
validation studies in order to consider caper as an
adjuvant agent for the treatment of metabolic diseases.
Antispasmodic effects
The relaxant effects of the aqueous extract of C. spinosa
fruits were demonstrated on rat trachea in a dose-
dependent manner (Benzidane et al., 2013). Wistar rat
trachea was excised and contracted with acetylcholine,
and bronchoactive effects of caper extracts were then
studied. At 1 and 10mg/mL the caper fruit aqueous
extract had a relaxant effect on acetylcholine pre-
contracted trachea. Blockage of Ca2+ influx through
voltage-dependent calcium channels may be involved
in this effect. On the other hand, leaf and seed extracts
gave contractile effects (Benzidane et al., 2013). These
results may be helpful in supporting the use of caper
extract in the treatment of asthmatic patients.
Bone regeneration
It is known that antioxidants exert a stimulatory effect
on bone metabolism through the inhibition of osteoclas-
tic activity and induction of osteoblastic one (Kara et al.,
2012). Given its demonstrated antioxidant properties,
caper was studied as a possible enhancer of bone regen-
eration (Erdogan et al., 2015). Ethanolic soxhlet extract
of caper buds was administered at 20mg/kg bw to male
Wistar albino rats, with maxillary incisions from applied
springs. After the consolidation period the animals were
sacrificed and stereological analysis was done on maxil-
lary expansion. Administration of caper extract pro-
duced significantly new bone area and volume, and
connective tissue space and volume compared to con-
trol. Results showed that the administration of caper ex-
tract accelerated osteoblastic activity in the early period.
Nematicidal activity
Methanolic extracts of different parts of C. spinosa
(leaves, stems and buds) were assayed as nematicidal
agents against the root knot Meloidogyne incognita by
the J2 paralysis bioassay (Caboni et al., 2012). Stem
extract was the most effective in inducing paralysis in
second stage nematode juveniles (J2). A dose-
dependent effect was noticed and significant
paralysis/death of J2 was observed after 3 days of expo-
sure. 2-Thiophenecarboxaldehyde and methyl isothiocy-
anate were the most abundant compounds in this
extract. These compounds were separately assayed for
nematicidal activity against J2. Both compounds were
able to induce paralysis on root knot M. incognita with
EC50 of 7.9 and 14.1mg/L, respectively. Moreover the
former compound showed strong fumigant activity.
With regards to the mode of action of these compounds,
authors assumed that they act as inhibitor of vacuolar
ATPase enzymes (Caboni et al., 2012). These results
may support future applications of caper as a biopesti-
cide for crop protection.
CONCLUSION AND FUTURE PROSPECTS
C. spinosa is known as one of the most important ed-
ible plants widely distributed worldwide. A wide range
of scientific evidence shows that C. spinosa possesses
multiple pharmacological effects. This paper aimed to
review the available literature regarding the pharma-
cological effects of this species. In conclusion, the ben-
eficial effects of C. spinosa are because of the high
number of bioactive natural products, especially poly-
phenolic compounds, although many of them occur
in low concentrations especially after fermentation.
In addition to this, there are no scientific reports re-
garding the adverse effects of its consumption. How-
ever, a search of the clinical trial database (https://
clinicaltrials.gov/ accessed February 14, 2015) with the
keywords ‘Caper’ and ‘Capparis spinosa’ showed that
there have only been three clinical trials conducted
on this plant. Therefore, it is very difficult to make a
clear decision regarding its clinical impact. However,
C. spinosa can be recommended for future clinical
trials aimed at evaluating its clinical efficacy and
safety. Finally, we recommend that future studies
should focus on:
• Identification, separation, purification and quantifica-
tion of the most bioactive constituents of C. spinosa,
taking into account the formation of new products
and the metabolization of some naturally occurring
substances driven by lactic acid bacteria during the
fermentation.
• Increasing the production of active constituents of C.
spinosa via biotechnological protocols.
• Increasing the bioavailability of most bioactive con-
stituents of C. spinosa by employing nanoparticles
and other modern strategies.
• Ascertain the most effective dose for future clinical
trials on the beneficial effects of C. spinosa.
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